|
C14ORF118 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.789790E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.6314999999958E-05 |
| Normal-vs-Stage2 |
4.152500E-02 |
| Normal-vs-Stage3 |
3.412200E-02 |
| Normal-vs-Stage4 |
3.082700E-03 |
| Stage1-vs-Stage2 |
3.114000E-01 |
| Stage1-vs-Stage3 |
3.662600E-01 |
| Stage1-vs-Stage4 |
6.097800E-01 |
| Stage2-vs-Stage3 |
8.854400E-01 |
| Stage2-vs-Stage4 |
3.097800E-01 |
| Stage3-vs-Stage4 |
3.963600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.644190E-04 |
| Normal-vs-AfricanAmerican |
6.952700E-04 |
| Normal-vs-Asian |
2.116100E-02 |
| Caucasian-vs-AfricanAmerican |
7.538000E-01 |
| Caucasian-vs-Asian |
6.567400E-01 |
| AfricanAmerican-vs-Asian |
6.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.159370E-04 |
| Normal-vs-Female |
1.672380E-01 |
| Male-vs-Female |
1.330500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.758300E-04 |
| Normal-vs-Extreme_Weight |
1.51121999999448E-05 |
| Normal-vs-Obese |
3.333600E-02 |
| Normal-vs-Extreme_Obese |
1.935160E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.827000E-01 |
| Normal_Weight-vs-Obese |
1.706980E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.287000E-01 |
| Extreme_Weight-vs-Obese |
3.092300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.738200E-01 |
| Obese-vs-Extreme_Obese |
2.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.560000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.824950E-03 |
| Normal-vs-Age(61-80Yrs) |
2.03749999999614E-05 |
| Normal-vs-Age(81-100Yrs) |
1.630760E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.977600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.489600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.075970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.178250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.296620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.871600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.67230000000563E-05 |
| Normal-VS-Type2 PRCC |
2.009500E-04 |
| Normal-VS-KIRP CIMP |
8.556600E-01 |
| Normal-VS-Unclassified PRCC |
1.595980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.376800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.594800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.640100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.433800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.001900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.294800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59110999999879E-05 |
| Normal-vs-N1 |
3.105400E-01 |
| Normal-vs-N2 |
5.699700E-03 |
| N0-vs-N1 |
1.373560E-01 |
| N0-vs-N2 |
4.392400E-01 |
| N1-vs-N2 |
2.917400E-01 |
|
|
